Director ISHII Ken
Some of the communicable diseases such as Mycobacterium tuberculosis, Malaria, HIV(AIDS), influenza virus, Ebola virus, MERS are continuously emerging and re-emerging in a global scale. In addition, non-communicable diseases such as allergy, cancer have been emerging health threat especially in developed countries. Given that most of those diseases involve mucosal area in their target organs, novel prevention and/or intervention targeting mucosal area would be attractive as well as unmet medical needs. Our center was established 2011 in order to facilitate the international collaborations among immunologists, microbiologists, cancer biologists, genome scientists and vaccinologists towards the ideal mucosal vaccine development. We also set an ambitious goal to nurture the next world leader scientist of the basic and applied science in the relevant field.